Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neurological

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Disease Area Drug discovery

Rejuvenating Alzheimer’s R&D

| Maryam Mahdi

How can we encourage companies to pursue clinical research for CNS disorders?

Disease Area Neurological

A Brave New World of Retina Research

| Allen C. Ho, Carl D. Regillo

Cutting-edge translational retina research for patients in Philadelphia and around the world

Tools & Techniques Clinical trials

Trials, Interrupted

| Carl D. Regillo

Chief of the Retina Service at Wills Eye Hospital discusses the impact of COVID-19 on retina research

Research Field Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system

Disease Area Infectious diseases

Rage Against the Dying of the Light

Sitting Down With… Jose Pulido, Larry A. Donoso Endowed Chair, Wills Eye

Disease Area Neurological

Getting on Target for Alzheimer’s

| Neil Cashman, James Kupiec

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

Tools & Techniques Diagnostics & prognostics

Seeing is Believing

| Jonathan James

Could changes in retinal blood vessels act as an early bio-marker for Alzheimer’s disease?

Research Field Cell & gene therapy

A Fighting Chance

| Neil Ebenezer

A new technique shows promising results for patients with sight loss from Leber congenital amaurosis

Research Field Neurological

Redirecting Cell Fate

| Jonathan James

A chemical cocktail of small molecules shows promise in driving neuro-regeneration.


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register